Liver and Biliary Pathology — MCQs

A patient presents with jaundice. Physical examination reveals an enlarged nodular liver. CT of the abdomen shows a cirrhotic liver with a large mass. CT-guided biopsy of the mass demonstrates a malignant tumor derived from hepatic parenchymal cells. Which of the following viruses is most directly related to the development of this tumor?

Q156Easy

What is the most common tumor of the liver found incidentally in healthy individuals?

Q157Easy

Which of the following is a causative agent for cholangiocarcinoma of the liver?

Q158Medium

Which of the following is considered a precancerous lesion of the gallbladder?

Q159Easy

In hemochromatosis, the liver is stained by which method?

Q160Medium

Which of the following statements is incorrect regarding Liver Kidney Microsomal (LKM) antibodies?

Liver and Biliary Pathology Indian Medical PG Practice Questions and MCQs

Question 151: How can Chronic Active Hepatitis best be differentiated from Chronic Persistent Hepatitis?

A. Hepatitis B surface antigen (HBsAg)
B. Antibody to Hepatitis B surface antigen (Anti-HBsAg)
C. Histopathology (Correct Answer)
D. None of the above

Explanation: **Explanation:** The differentiation between **Chronic Active Hepatitis (CAH)** and **Chronic Persistent Hepatitis (CPH)** is based primarily on the **morphological pattern of liver injury**, making **Histopathology** the gold standard for diagnosis [1]. 1. **Why Histopathology is Correct:** * **Chronic Persistent Hepatitis (CPH):** Characterized by inflammatory infiltrates (mostly lymphocytes) confined strictly to the **portal tracts**. The limiting plate (the layer of hepatocytes bordering the portal tract) remains intact [2]. * **Chronic Active Hepatitis (CAH):** Characterized by **"Piecemeal Necrosis"** (Interface Hepatitis). The inflammation spills over the portal tracts into the surrounding parenchyma, causing destruction of the limiting plate [2]. It may also show "bridging necrosis" (portal-to-portal or portal-to-central vein), which carries a high risk of progression to cirrhosis [2]. 2. **Why Other Options are Incorrect:** * **HBsAg and Anti-HBsAg:** These are serological markers used to identify the **etiology** (Hepatitis B infection) or immune status. They do not provide information regarding the degree of necro-inflammatory activity or the structural integrity of the liver lobule [1]. Both CAH and CPH can occur in a patient who is HBsAg positive. **NEET-PG High-Yield Pearls:** * **Interface Hepatitis (Piecemeal Necrosis):** The hallmark of Chronic Active Hepatitis. * **Ground Glass Hepatocytes:** Seen in Chronic Hepatitis B due to HBsAg accumulation in the endoplasmic reticulum [1]. * **Councilman Bodies:** Eosinophilic, apoptotic hepatocytes seen in acute viral hepatitis (but can also be seen in chronic forms). * **Staging vs. Grading:** In histopathology, **Grading** refers to the severity of necro-inflammatory activity (e.g., Ishak score), while **Staging** refers to the degree of fibrosis/cirrhosis [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 843-844. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, p. 844.

Question 152: Which of the following is NOT a risk factor for Hepatocellular Carcinoma?

A. Hepatitis B Virus (HBV)
B. Hepatitis C Virus (HCV)
C. Alcohol
D. Irritable Bowel Syndrome (IBS) (Correct Answer)

Explanation: Hepatocellular Carcinoma (HCC) is the most common primary malignancy of the liver, typically arising in the setting of chronic liver injury and cirrhosis [1]. **Why Irritable Bowel Syndrome (IBS) is the correct answer:** IBS is a functional gastrointestinal disorder characterized by abdominal pain and altered bowel habits without any structural or biochemical abnormalities. It does not involve chronic inflammation, fibrosis, or cellular dysplasia of the liver. Therefore, it has no association with the development of HCC. In contrast, **Inflammatory Bowel Disease (IBD)**, specifically Ulcerative Colitis, is a risk factor for *Cholangiocarcinoma* (via Primary Sclerosing Cholangitis), but not directly for HCC. **Why the other options are incorrect:** * **Hepatitis B (HBV):** A major risk factor worldwide [3]. HBV can cause HCC even in the absence of cirrhosis because it is a DNA virus that integrates into the host genome, leading to genomic instability [2]. * **Hepatitis C (HCV):** A leading cause of HCC in developed nations [3]. Unlike HBV, HCV is an RNA virus and almost always induces HCC through the pathway of chronic inflammation and established cirrhosis [2]. * **Alcohol:** Chronic alcohol consumption leads to alcoholic steatohepatitis and eventually cirrhosis, which provides the proliferative environment necessary for hepatocarcinogenesis [1]. **NEET-PG High-Yield Pearls:** * **Most common cause of HCC worldwide:** HBV infection [3]. * **Most common cause of HCC in the West:** HCV and NAFLD/NASH. * **Aflatoxin B1:** A potent dietary carcinogen (from *Aspergillus flavus*) that causes a specific mutation in the **p53 gene (codon 249)**, significantly increasing HCC risk [1]. * **Tumor Marker:** Serum **Alpha-fetoprotein (AFP)** is used for screening and monitoring, though it is not 100% specific. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 876-877. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 336-337. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 215-216.

Question 153: All of the following are true about chronic venous congestion of the liver except?

A. Gamna Gandy bodies are seen (Correct Answer)
B. Nutmeg liver is seen
C. Dilated blood channels are seen
D. None of the above

Explanation: In Chronic Venous Congestion (CVC) of the liver, the primary pathology is back-pressure from the right heart, leading to congestion of the centrilobular regions [1][2]. **Why Option A is the Correct Answer (The "Except"):** **Gamna-Gandy bodies** (siderofibrotic nodules) are characteristic of **Chronic Venous Congestion of the Spleen**, not the liver. They are small, firm, brown-to-yellow nodules composed of fibrous tissue, elastic fibers, and deposits of iron (hemosiderin) and calcium, resulting from focal hemorrhages within the splenic follicles. **Analysis of Incorrect Options:** * **Option B (Nutmeg Liver):** This is a classic gross finding in CVC liver [1]. The "nutmeg" appearance is caused by the contrast between the **congested, red-brown centrilobular zones** (Zone 3) and the **pale, fatty, or normal periportal zones** (Zone 1) [2]. * **Option C (Dilated blood channels):** Microscopically, CVC liver is characterized by marked **dilation of the central veins and sinusoids** [1]. This congestion leads to pressure atrophy and necrosis of hepatocytes in the centrilobular area (Zone 3), as it is furthest from the arterial blood supply [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Cardiac Cirrhosis:** Prolonged, severe CVC liver can lead to centrilobular fibrosis, eventually resulting in "cardiac cirrhosis" [2]. * **Zone 3 Vulnerability:** In the liver acinus, Zone 3 (centrilobular) is the most susceptible to both hypoxia (ischemia) and congestion [2]. * **Spleen vs. Liver:** Remember: **Nutmeg = Liver**; **Gamna-Gandy = Spleen**. * **Stain for Gamna-Gandy:** Perls' Prussian Blue (for iron) and Von Kossa (for calcium). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, p. 126. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 870-872.

Question 154: Which of the following is the single most important indicator of the likelihood of progression of hepatitis to liver cirrhosis?

A. Etiology (Correct Answer)
B. Associated serological findings
C. Presence of bridging necrosis
D. Presence of Mallory hyaline

Explanation: In the context of chronic hepatitis, the **etiology (cause)** is the single most important predictor of whether the disease will progress to cirrhosis. [1] ### **Why Etiology is the Correct Answer** The natural history of hepatitis is dictated primarily by the underlying cause. For example, Hepatitis B (HBV) and Hepatitis C (HCV) have vastly different rates of chronicity and progression. [1] While 90% of adults with HBV recover completely, approximately 80% of those with HCV develop chronic infection, significantly increasing the risk of cirrhosis. Similarly, autoimmune hepatitis or Wilson’s disease carries a much higher risk of rapid progression compared to certain drug-induced liver injuries. While histological features (like bridging necrosis) indicate current severity, the **etiology** determines the persistence of the insult and the ultimate prognosis. [2] ### **Analysis of Incorrect Options** * **B. Associated serological findings:** These are useful for diagnosis (e.g., HBsAg, Anti-HCV) and monitoring viral load, but they are markers of the etiology rather than independent predictors of cirrhosis. [1] * **C. Presence of bridging necrosis:** This is a histological feature of "Grade" (activity). While bridging necrosis (portal-to-portal or portal-to-central) indicates a higher risk of progression than simple piecemeal necrosis, it is a snapshot in time. Without knowing the etiology, one cannot predict if the necrosis will resolve or lead to permanent scarring. [2] * **D. Presence of Mallory hyaline:** These are eosinophilic cytoplasmic inclusions (cytokeratin intermediate filaments) most commonly associated with Alcoholic Liver Disease. [1] While they indicate cell injury, they are neither specific to cirrhosis nor the primary driver of progression. ### **NEET-PG High-Yield Pearls** * **Grading vs. Staging:** In liver pathology, **Grade** refers to the degree of inflammation and necrosis (activity), while **Stage** refers to the degree of fibrosis/cirrhosis. [2] * **HCV Fact:** Hepatitis C is the most common cause of post-transfusion hepatitis and a leading cause of cirrhosis and HCC worldwide. [1] * **Ground Glass Hepatocytes:** Characteristic histological finding in chronic Hepatitis B (due to HBsAg accumulation in the ER). [1], [2] **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 388-392. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 843-845.

Question 155: A patient presents with jaundice. Physical examination reveals an enlarged nodular liver. CT of the abdomen shows a cirrhotic liver with a large mass. CT-guided biopsy of the mass demonstrates a malignant tumor derived from hepatic parenchymal cells. Which of the following viruses is most directly related to the development of this tumor?

A. Epstein-Barr virus
B. Human Herpes virus type 6
C. Human T-lymphotropic virus
D. Hepatitis B virus (Correct Answer)

Explanation: **Explanation:** The clinical presentation of jaundice, a nodular liver, and a mass in a cirrhotic liver strongly suggests **Hepatocellular Carcinoma (HCC)**. The biopsy confirms a malignancy derived from hepatic parenchymal cells (hepatocytes) [2]. **1. Why Hepatitis B Virus (HBV) is correct:** HBV is a leading cause of HCC worldwide [3]. It promotes oncogenesis through two main pathways: * **Indirectly:** Chronic inflammation and cycles of hepatocyte death and regeneration (cirrhosis) increase the risk of spontaneous mutations [1]. * **Directly:** Unlike HCV (an RNA virus), HBV is a DNA virus that can **integrate its genome into the host DNA**. This can cause genomic instability and activate proto-oncogenes (like the *HBx* protein, which inhibits p53 and activates the Wnt/β-catenin pathway) [1]. **2. Why the other options are incorrect:** * **A. Epstein-Barr virus (EBV):** Associated with Burkitt lymphoma, Nasopharyngeal carcinoma, and Hodgkin lymphoma, but not HCC. * **B. Human Herpes virus type 6 (HHV-6):** Causes Roseola infantum; it is not linked to hepatic malignancy. * **C. Human T-lymphotropic virus (HTLV-1):** Directly linked to Adult T-cell Leukemia/Lymphoma (ATLL). **High-Yield Clinical Pearls for NEET-PG:** * **Tumor Marker:** Alpha-fetoprotein (AFP) is the most common marker for HCC [4]. * **Aflatoxin B1:** A potent co-carcinogen for HCC (produced by *Aspergillus flavus*) that causes a specific mutation in the **p53 gene (codon 249)** [2]. * **Fibrolamellar Variant:** A subtype of HCC seen in young adults without cirrhosis; it has a better prognosis and is characterized by "onocytic" hepatocytes and parallel collagen bundles. * **Vascular Invasion:** HCC has a high propensity for invading the hepatic and portal veins. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 336-337. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 876-877. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 215-216. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 399-400.

Question 156: What is the most common tumor of the liver found incidentally in healthy individuals?

A. Hemangioma (Correct Answer)
B. Adenoma
C. Lymphoma
D. Hamartoma

Explanation: **Explanation:** **Correct Answer: A. Hemangioma** Cavernous hemangiomas are the **most common benign primary tumors of the liver**. [1] They are typically small (less than 5 cm), solitary, and asymptomatic. Because they rarely cause clinical symptoms, they are most frequently discovered as **incidental findings** during abdominal imaging (ultrasound or CT) or at autopsy in otherwise healthy individuals. [1] Pathologically, they consist of large, blood-filled vascular channels lined by a single layer of endothelium. [1] **Why other options are incorrect:** * **B. Adenoma:** Hepatic cell adenomas are less common and strongly associated with **oral contraceptive pill (OCP)** use or anabolic steroids. [1] Unlike hemangiomas, they carry a risk of life-threatening rupture (especially during pregnancy) and malignant transformation. [1] * **C. Lymphoma:** Primary hepatic lymphoma is extremely rare. Secondary involvement of the liver by systemic lymphoma is more common but occurs in the context of known malignancy, not in "healthy individuals." * **D. Hamartoma:** Mesenchymal hamartomas are rare benign tumors primarily seen in the **pediatric population** (usually under age 2), not typically found in healthy adults. **NEET-PG High-Yield Pearls:** * **Most common liver tumor overall:** Metastatic carcinoma (most commonly from colon, lung, or breast). * **Most common primary malignant liver tumor:** Hepatocellular Carcinoma (HCC). * **Imaging characteristic of Hemangioma:** On contrast CT, they show **peripheral globular enhancement** with "centripetal fill-in" (filling from the periphery toward the center). * **Biopsy Caution:** Biopsy is generally avoided in suspected hemangiomas due to the risk of significant hemorrhage. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, p. 874.

Question 157: Which of the following is a causative agent for cholangiocarcinoma of the liver?

A. Hepatitis B infection
B. Cirrhosis of the liver
C. Alpha-fetoprotein
D. Clonorchis sinensis infection (Correct Answer)

Explanation: **Explanation:** **Cholangiocarcinoma** is a malignancy arising from the epithelial lining of the intrahepatic or extrahepatic bile ducts [1]. **Why Option D is Correct:** *Clonorchis sinensis* (the Chinese liver fluke) and *Opisthorchis viverrini* are well-established risk factors for cholangiocarcinoma. These parasites reside in the biliary tree, causing chronic inflammation, biliary stasis, and mucosal hyperplasia. This persistent irritation leads to DNA damage and malignant transformation of the cholangiocytes. This is a high-yield association frequently tested in exams. **Analysis of Incorrect Options:** * **Option A (Hepatitis B):** HBV is a primary risk factor for **Hepatocellular Carcinoma (HCC)**, not cholangiocarcinoma [2]. While chronic inflammation can theoretically increase cancer risk, the association with HCC is significantly stronger. * **Option B (Cirrhosis):** While cirrhosis is the strongest predisposing factor for HCC [3], it is not a primary driver for cholangiocarcinoma. Risk factors for cholangiocarcinoma are more specific to the biliary tree (e.g., Primary Sclerosing Cholangitis, Caroli disease, and Thorotrast exposure). * **Option C (Alpha-fetoprotein):** AFP is a **tumor marker** used for the diagnosis and monitoring of HCC [3]. It is not a causative agent. Furthermore, AFP levels are typically normal in patients with cholangiocarcinoma (where CA 19-9 is more commonly elevated). **NEET-PG High-Yield Pearls:** 1. **Primary Sclerosing Cholangitis (PSC):** The most common predisposing factor for cholangiocarcinoma in Western countries. 2. **Morphology:** Most cholangiocarcinomas are well-differentiated **adenocarcinomas** producing mucin [1]. 3. **Klatskin Tumor:** A specific type of cholangiocarcinoma occurring at the junction of the right and left hepatic ducts (hilar region). 4. **Tumor Markers:** HCC = AFP; Cholangiocarcinoma = CA 19-9 and CEA. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 879-880. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 876-877. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 399-400.

Question 158: Which of the following is considered a precancerous lesion of the gallbladder?

A. Porcelain gallbladder (Correct Answer)
B. Mirizzi's syndrome
C. Cholesterolosis
D. Acalculous cholecystitis

Explanation: **Explanation:** **1. Why Porcelain Gallbladder is correct:** Porcelain gallbladder refers to the extensive **intramural calcification** of the gallbladder wall, typically resulting from chronic cholecystitis. It is considered a significant precancerous lesion because it is associated with an increased risk of **Gallbladder Carcinoma (GBC)**. While older studies suggested a risk as high as 20-25%, modern data suggests a lower but still significant risk (approx. 7-15%), particularly when the calcification is "selective" or "punctate" (mucosal) rather than complete transmural calcification. Prophylactic cholecystectomy is generally recommended. **2. Why the other options are incorrect:** * **Mirizzi’s Syndrome:** This is a clinical condition where a gallstone impacted in the cystic duct or gallbladder neck causes extrinsic compression of the Common Hepatic Duct (CHD), leading to obstructive jaundice. It is an inflammatory complication, not a premalignant one. * **Cholesterolosis:** Also known as "Strawberry Gallbladder," this involves the accumulation of cholesterol-laden macrophages in the lamina propria (xanthoma cells). It is a benign metabolic finding and does not increase the risk of malignancy. * **Acalculous Cholecystitis:** This is acute inflammation of the gallbladder in the absence of gallstones, often seen in critically ill patients (burns, sepsis, major trauma) [2]. It is a surgical emergency but not a precursor to cancer. **3. NEET-PG High-Yield Pearls:** * **Most common risk factor for GBC:** Gallstones (Cholelithiasis), especially stones >3 cm [3]. * **Other Precancerous Lesions:** Adenomatous polyps (>10mm), Choledochal cysts (Type I and IV), and Anomalous Pancreaticobiliary Duct Junction (APBDJ). * **Histology:** Most gallbladder cancers are **Adenocarcinomas** [1]. * **Radiology:** Porcelain gallbladder appears as a curvilinear, echogenic rim with posterior shadowing on ultrasound, or a "rim of calcification" on CT. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, p. 886. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 883-884. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 403-404.

Question 159: In hemochromatosis, the liver is stained by which method?

A. Perl's iron stain (Correct Answer)
B. Alcian blue
C. Congo Red
D. Masson's trichrome

Explanation: **Explanation:** **1. Why Perl’s Iron Stain is Correct:** Hemochromatosis is a disorder of iron overload where excessive iron is deposited in parenchymal cells (hemosiderosis). **Perl’s Prussian Blue** is the gold-standard histochemical stain for detecting ferric iron ($Fe^{3+}$) [1]. In this reaction, potassium ferrocyanide reacts with ferric iron in the tissue to form an insoluble bright blue pigment called **ferric ferrocyanide** (Prussian blue). In the liver, this stain highlights coarse blue granules within hepatocytes and bile duct epithelium, allowing for the calculation of the Hepatic Iron Index [1]. **2. Analysis of Incorrect Options:** * **Alcian Blue:** Used to identify **acid mucopolysaccharides** (mucins). It is commonly used to diagnose Barrett’s esophagus or certain mucin-secreting tumors. * **Congo Red:** The specific stain for **Amyloid**. Under polarized light, amyloid stained with Congo Red exhibits a characteristic "apple-green birefringence." * **Masson’s Trichrome:** Used to visualize **connective tissue (collagen)**. In liver pathology, it is essential for staging fibrosis and diagnosing cirrhosis by staining collagen fibers blue/green against a red cytoplasmic background [1]. **3. NEET-PG High-Yield Pearls:** * **Hereditary Hemochromatosis:** Most commonly due to a mutation in the **HFE gene (C282Y)** on Chromosome 6. * **Classic Triad:** "Bronze diabetes" (Cirrhosis, Diabetes Mellitus, and Skin hyperpigmentation). * **Hepatocellular Carcinoma (HCC):** Patients with hemochromatosis have a 200-fold increased risk of developing HCC. * **Distinction:** Perl’s stain reacts with **Hemosiderin** (ferric iron) but does *not* stain Ferritin or Hemoglobin directly [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 854-855.

Question 160: Which of the following statements is incorrect regarding Liver Kidney Microsomal (LKM) antibodies?

A. Anti-LKM1 antibodies are associated with autoimmune hepatitis.
B. Anti-LKM2 antibodies are associated with drug-induced hepatitis.
C. Anti-LKM1 antibodies can be found in chronic hepatitis C.
D. Anti-LKM2 antibodies are associated with chronic hepatitis D. (Correct Answer)

Explanation: ### Explanation **1. Why Option D is the Correct (Incorrect Statement):** Anti-LKM2 antibodies are specifically associated with **drug-induced hepatitis**, particularly that caused by **Ticrynafen** (a diuretic no longer in use). They are **not** associated with Hepatitis D. The antibody associated with Hepatitis D (HDV) is actually **Anti-LKM3**, which targets the enzyme UDP-glucuronosyltransferase. **2. Analysis of Other Options:** * **Option A:** Anti-LKM1 antibodies are the hallmark of **Type 2 Autoimmune Hepatitis (AIH)** [1]. They target the enzyme **Cytochrome P450 2D6 (CYP2D6)** [1]. This type typically affects children and young girls [1]. * **Option B:** As mentioned, Anti-LKM2 is the classic marker for Ticrynafen-induced liver injury, making this a correct statement. * **Option C:** Interestingly, up to 10% of patients with **Chronic Hepatitis C** can test positive for Anti-LKM1 antibodies. This is a high-yield fact as it can complicate the diagnosis between viral and autoimmune hepatitis. **3. High-Yield Clinical Pearls for NEET-PG:** * **LKM-1:** Type 2 Autoimmune Hepatitis (Target: CYP2D6) [1]. * **LKM-2:** Drug-induced (Ticrynafen). * **LKM-3:** Chronic Hepatitis D (Target: UGT-1). * **Type 1 AIH:** Most common type; associated with **ANA** (Anti-Nuclear Antibody) and **ASMA** (Anti-Smooth Muscle Antibody) [1]. * **SLA/LP Antibody:** Soluble Liver Antigen/Liver Pancreas antibody is the most specific marker for Autoimmune Hepatitis [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 845-846.

Practice by Chapter

Jaundice and Cholestasis

Practice Questions

Viral Hepatitis

Practice Questions

Alcoholic and Non-alcoholic Fatty Liver Disease

Practice Questions

Drug and Toxin Induced Liver Injury

Practice Questions

Cirrhosis and Its Complications

Practice Questions

Metabolic Liver Diseases

Practice Questions

Liver Tumors

Practice Questions

Gallbladder and Biliary Tract Diseases

Practice Questions

Congenital Liver Diseases

Practice Questions

Liver Transplantation Pathology

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free